SGAM
IMMU

Smith Group Asset Management’s Immunomedics Inc IMMU Stock Holding History

Smith Group Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-5,480
Closed -$194K – 348
2020
Q2 		$194K Sell
5,480
-80
-1% -$2.34K 0.01% 167
2020
Q1 		$75K Hold
5,560
– – ﹤0.01% 228
2019
Q4 		$118K Hold
5,560
– – ﹤0.01% 233
2019
Q3 		$74K Buy
5,560
+1,690
+44% +$24.8K ﹤0.01% 254
2019
Q2 		$54K Hold
3,870
– – ﹤0.01% 268
2019
Q1 		$74K Sell
3,870
-11,100
-74% -$179K ﹤0.01% 279
2018
Q4 		$214K Sell
14,970
-200
-1% -$3.97K 0.01% 238
2018
Q3 		$316K Buy
+15,170
New +$359K 0.01% 218
2015
Q3 		– Sell
-211,100
Closed -$857K – 441
2015
Q2 		$857K Buy
211,100
+3,890
+2% +$15.9K 0.03% 177
2015
Q1 		$794K Buy
+207,210
New +$901K 0.03% 184

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

Smith Group Asset Management's IMMU Position: Q3 2020 in Review

Smith Group Asset Management sold out of Immunomedics Inc (IMMU) in Q3 2020, closing a stake of 5,480 shares — an estimated $194K sold.

Smith Group Asset Management first reported a position in IMMU in Q1 2015 and held it in 10 quarters. The position peaked at $857K in Q2 2015. 408 funds tracked by Wall St. Rank hold IMMU as of Q3 2020.

  • Smith Group Asset Management reported no remaining Immunomedics Inc position as of Q3 2020 after selling out during the quarter.
  • Smith Group Asset Management sold 5,480 Immunomedics Inc shares in Q3 2020, an estimated $194K.
  • Smith Group Asset Management first reported a position in Immunomedics Inc in Q1 2015 and held it in 10 quarters.
  • Smith Group Asset Management's Immunomedics Inc position peaked at $857K in Q2 2015.
  • 408 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2020.

Based on Smith Group Asset Management's 13F filing for Q3 2020, filed 4 Nov 2020.